EGFR and non-small cell lung carcinoma: We hypothesized that a DL-based representation framework could identify significant CT-based image features associated with disease progression in patients with stage IV EGFR variant–positive NSCLC and thereby contribute to identifying patient cohorts more likely to benefit from EGFR-TKI therapy.